The FDA approved Mitsubishi Tanabe Pharma's edaravone for amyotrophic lateral sclerosis (ALS), the first US approval for the deadly neurodegenerative disease since riluzole in 1995.ALS is a rare disease that attacks and kills the nerve cells that control voluntary muscles, affecting the ability

中文翻译：

---

FDA批准了20多年来首款新的ALS药物

FDA批准三菱田边制药的依达拉奉用于肌萎缩性侧索硬化症（ALS），这是自riluzole以来自1995年以来美国首次批准致命的神经退行性疾病.ALS是一种罕见的疾病，会攻击并杀死控制自愿肌肉的神经细胞，从而影响能力